YTHDF2 was reported to recognize and bind m6A-modified GSK3β mRNA to promote its degradation, which subsequently decreased the phosphorylation of β-catenin to enhance the stability of the β-catenin protein, thereby promoting CRC cell proliferation [49]. The gene discussed is YTHDF2; the disease is colorectal carcinoma.